Cite
HARVARD Citation
Di Mario, F. et al. (n.d.). P.02.7: The Branded Proton Pump Inhibitors (PPIS) Increase Levels of Gastrin 17 (G-17) More than the Generic Ones in Dyspeptic Patients from an Italian Primary Care Population. Digestive and liver disease. pp. e140-e141. [Online].